Viewing Study NCT01903395


Ignite Creation Date: 2025-12-24 @ 2:16 PM
Ignite Modification Date: 2026-02-24 @ 10:20 PM
Study NCT ID: NCT01903395
Status: COMPLETED
Last Update Posted: 2016-10-25
First Post: 2013-07-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Risk-adapted Screening in First-degree Relatives of Patients With Colorectal Cancer
Sponsor: Martin-Luther-Universität Halle-Wittenberg
Organization:

Study Overview

Official Title: Nurse-led Colon Cancer Risk Counseling for First-degree Relatives to Enhance Use of Colonoscopy
Status: COMPLETED
Status Verified Date: 2016-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: FAMKOL
Brief Summary: BACKGROUND: First-degree relatives of patients with colorectal cancer are at increased risk for colorectal cancer as well. Nevertheless, participation in the German national screening program stagnates at 2-3 percent per year even in this high-risk population.

AIM: The study is aimed to increase the portion of the first-degree relatives on 50% which take up a preventive colonoscopy.

METHODS: Cluster-randomized controlled multi-center trial. Study sites (clusters) are mainly certified cancer centers and office-based gastroenterologists from all over Germany. Index-patients with colorectal cancer of different stages are asked to hand over the study material to their relatives, consisting of an invitation to a nurse-led counseling on preventive colonoscopy and an one-to-one appointment with a clinical expert of one of the study sites next.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: